Fennec Pharmaceuticals (FENC) Assets (2016 - 2025)
Historic Assets for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to $49.3 million.
- Fennec Pharmaceuticals' Assets fell 1639.48% to $49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.3 million, marking a year-over-year decrease of 1639.48%. This contributed to the annual value of $44.9 million for FY2024, which is 6730.94% up from last year.
- Per Fennec Pharmaceuticals' latest filing, its Assets stood at $49.3 million for Q3 2025, which was down 1639.48% from $44.9 million recorded in Q2 2025.
- Over the past 5 years, Fennec Pharmaceuticals' Assets peaked at $69.2 million during Q1 2024, and registered a low of $15.6 million during Q2 2022.
- Its 5-year average for Assets is $35.5 million, with a median of $28.0 million in 2021.
- As far as peak fluctuations go, Fennec Pharmaceuticals' Assets crashed by 4462.74% in 2022, and later surged by 22495.24% in 2024.
- Quarter analysis of 5 years shows Fennec Pharmaceuticals' Assets stood at $26.0 million in 2021, then increased by 3.56% to $26.9 million in 2022, then fell by 0.28% to $26.9 million in 2023, then soared by 67.31% to $44.9 million in 2024, then grew by 9.6% to $49.3 million in 2025.
- Its Assets was $49.3 million in Q3 2025, compared to $44.9 million in Q2 2025 and $46.4 million in Q1 2025.